win666 niceph
Trump Does It Again: The Rise of New Media Share This article Donald Trump's win in November caused seismic waves across the country, and it shook up more than just politics. It served as a clear wakeup call to legacy media outlets. "They're doing soul searching, and I think it's going to be reflected in some of the content we see on the air and on websites and in newspapers," says veteran journalist Howard Polskin who now reports on the media. "I think everyone is going to be a lot more measured." MSNBC hosts Joe Scarborough and Mika Brezinski quickly saw the writing on the wall. "They are overseeing a sinking ship," says Curtis Houck with Newsbusters. "Joe and Mika, you could think of as the captains of the USS Resistance." After being vocal Trump critics, they met with the president-elect at Mar-a Lago and are now starting to play nice as they made clear recently on the broadcast. "Joe and I realize it's time to do something different," Brezinski told viewers. "That starts with not only talking about Donald Trump but also talking with him." The move by Joe and Mika makes sense based on ratings alone. Following the election, MSNBC's total viewership dropped 38% and CNN is down 27%. Houck sees this as desperate times. "Part of that desperation is going to meet with the 'fascist' himself," Houck tells CBN News. "And they've admitted in previous weeks that they want to do the show differently, which I take that to mean, perhaps go back to the Morning Joe that it used to be." But it might be too late to do any good. Trust in the media has been fading for years. Back in 1972, only 6 percent of Americans said they didn't trust the media. By the Clinton years in 1997, that number increased to 15 percent. When Trump first took office, it jumped to 24 percent and now, 8 years later, 36 percent of Americans don't trust the media at all. "That is such an extraordinary number, and it should be a shock wave in newsrooms across this country," says John Solomon, the CEO of Just The News. "Unfortunately, most newsrooms are still in denial...so I fear the pattern of misreporting, of loss of audience, loss of connection with audience, loss of perspective with audience, is going to continue." In this news media landscape, we're already seeing a trend of out with the old and in with the new. Trump took advantage of this and added a new wrinkle in 2024 by reaching out to podcasters, streaming services and social media influencers. "You saw him go after podcast platforms," Houck says. "He talked to his son, Barron, about this. He had a young comms team that thought about, where do young people get their news?" CHECK OUT CBN News on Rumble! Houck believes Trump has changed the way campaigns will communicate in the future: more emphasis on casual connection and far less on what's seen as traditional media. "Candidates venturing into the podcast sphere, new media atmosphere, whatever you want to call it, is this generation's question of yesteryear, of which candidate would I want to get a beer with." This new playing field could pit two media classes against each other with the battle playing out at The White House itself. The legacy media has encamped in the briefing room for decades. John Solomon, though, recounts to CBN News a conversation with Trump in 2020 when talk had already begun about shaking up how business is done. "I would not be surprised if you saw in a few weeks, the announcement of a creation of a new White House Correspondents Association and an alternate correspondence association," Solomon speculates. That could mean a group of more conservative outlets and possibly popular podcasters. "Maybe create a second press room," Solomon says. "Maybe it's in the Old Executive Office Building, which was where the discussions were in August of 2020, and let new media come in and let's see who covers the press conference more accurately, more fairly." Whether that happens or not, it's clear this new media landscape is spreading from print and television to the social media terrain. With the platform X now owned by Trump-supporting Elon Musk, liberals are fleeing in droves, moving to Bluesky, started by Twitter Founder and former CEO Jack Dorsey. "The news environment is going to be atomized even more," says veteran journalist Howard Polskin with the website therighting.com . "So now you're going to have social media platforms just for mainstreamers and liberals. You're going to have some just for the near right. Then you're going to have social media for the far right...that's just how the media business is going these days." It's all moving very fast. Just the way Trump likes it. ***Please sign up for CBN Newsletters and download the CBN News app to receive the latest news alerts and updates from a distinctly Christian perspective New Trump DOJ Nominee Harmeet Dhillon Called a 'Huge Win for Life', Would Replace Official Who Targeted Pro-Lifers https://t.co/ArrV2udoqx pic.twitter.com/qs2uDgo2o3 Share This article About The AuthorAs in 2023, investors were once again captivated by the potential of artificial intelligence (AI) in 2024. But not every stock has benefited. Sure, Nvidia and Broadcom have had great years, but not every AI beneficiary was as fortunate. Why would that be? For one, many traders look at results in the here and now. So, if a company had a near-term slip-up or a slowdown, their stocks were likely punished -- even if AI should provide a long-term tailwind for their business. The following three examples were laggards in 2024, but looking ahead to 2025, they appear to be excellent pickups on the dips . ASML Holdings There would be no AI semiconductors at all without the extreme ultraviolet lithography (EUV) tools provided by ASML Holdings ( ASML -0.65% ) , which has a monopoly on this crucial chipmaking technology. In that light, why would ASML's stock be down about 4% on the year and 35% from all-time highs? The market appears to be honing in on a few short-term concerns. The first is China, where ASML has seen a surge of older and less-sophisticated deep ultraviolet lithography (DUV) sales in recent years, ahead of more stringent restrictions placed on equipment from China this year. Although ASML will continue selling to China, they will no longer be able to sell or service several types of machines, so that pull-in of China sales this year could lead to ASML's China revenue declining next year. In addition, while the AI market is booming, larger, mature chip markets, like smartphones and PCs, have continued to languish for longer than expected in their post-pandemic lull. That recently led some foundries to pull back a bit on their near-term spending plans. However, ASML still projects growth next year, even if it's lower than previously expected. More importantly, at the company's recent investor day, management kept its 2030 revenue and earnings targets intact. Advanced chip production will now require more EUV machines versus DUV machines, and EUV machines are higher-revenue and higher-margin for ASML. Even better, ASML's higher-priced high numerical aperture (NA) EUV machines, which go for about twice the price of the low-NA EUV machines in use today, have just started selling this year. The growth and increasing mix of advanced EUV machines should lead to margin expansion, fueling solid profit growth through this decade at least. With the long-term picture intact and ASML's competitive position nearly assured, long-term investors should buy this dip with both hands. MongoDB Artificial intelligence applications will have to reference lots of data and make sense of it all incredibly quickly, which will put a lot of importance on how that data is stored in a database. MongoDB ( MDB 0.26% ) has a disruptive architecture for databases, called a document architecture, which allows for more intuitive organization of unstructured data than the traditional SQL (structured query language) database, which stores data in a more restrictive row-and-column format. If one thinks about the kinds of data relationships AI agents will have to retrieve and make sense of, MongoDB's document databases look increasingly better. Not only that, AI has recently made it much easier for enterprises to migrate legacy applications from traditional databases to MongoDB. To date, that has been a complex process leading to customer friction. Despite these positives, MongoDB's stock is down 35% year to date and more than 50% below its all-time high. Why would that be? According to management, the uncertain macro environment and companies figuring out what to do with AI have caused a slowdown in MongoDB Atlas usage. Basically, while companies are experimenting and learning about AI's potential, very few "killer app" AI software applications have caught on as of yet. However, as AI improves and companies increasingly figure out how to deploy AI applications, AI app usage should take off. As a majority of MongoDB's revenue comes from its usage-based Atlas database-as-a-service, MongoDB will see the benefit in the building and usage of AI apps. However, we are not quite at that stage. CEO Dev Ittycheria noted on the recent conference call with analysts that while many AI apps don't yet have good product-market fit, some are beginning to, with Ittycheria highlighting one such app built on MongoDB that has grown 10 times over the course of the year. As the AI revolution moves from the infrastructure buildout to software applications, MongoDB should see an acceleration in usage. Trading near a historically low price-to-sales ratio of around 10, MongoDB could see a bounce-back year in 2025. On Semiconductor Most don't equate On Semiconductor ( ON 1.08% ) with AI, as its biggest business is in power chips for the automotive industry . Specifically, onsemi is the current leader in producing chips from silicon carbide (SiC), a material that's somewhat difficult to produce but is much more conductive and heat-resistant than traditional silicon. SiC is thought to be crucial for future electric vehicles (EVs), and given the big slowdown in the EV market, onsemi is down 20% on the year and 40% off its all-time highs. But with the extreme electricity demands of AI data centers and the latest AI chips generating tons of heat, silicon carbide is now making its way into power control systems for AI data centers, too. This year, onsemi unveiled its EliteSiC 650V MOSFET for AI data centers, and management has invested early to get behind this trend. While AI data centers are a small portion of onsemi's revenues today, look for that to get bigger over time. Meanwhile, onsemi doesn't just make power chips; it makes sensors, too, especially for intelligent sensing needed in advanced driver assistance systems (ADAS) for modern cars and trucks. And while 2024 was a down-cycle year for the auto industry overall, onsemi did land several large and important customer wins, including a huge multiyear deal with Volkswagen , the largest automaker in the world by revenue, and deals with Subaru and Denso , the world's second-largest auto systems supplier. At just 16.5 times bottom-of-the-cycle earnings, look for onsemi to outperform when the auto and EV markets recover and the company's chips make their way into more AI applications.
A 47-year-old accountant lost Rs7 lakh after clicking on an unknown link, which directed her to a fake investment WhatsApp group. The members regularly shared information about stock market seminars and lucrative profit opportunities, making her believe that they were genuine. According to the Matunga police, the complainant, Sitalakshmi Iyer, has basic knowledge of the stock market and has even made a few investments. In March, she received a link on her phone and got added to a WhatsApp group after clicking on it. The group's administrator, Priya Patel, lured Iyer to invest in the market, promising her 200-300% returns. Initially, the complainant transferred Rs4.8 lakh and subsequently gave the remaining amount after seeing her profits rise to Rs10 lakh on a bogus digital platform. However, when Iyer tried to withdraw the funds, she was asked to deposit additional money. She then requested the scammers to deduct the commission from the profits and give back the amount which she invested, but they refused. Iyer and her husband attempted to contact the scammers multiple times through calls and messages, but received no response.Freezer Bags Market Insights into the Future of through Consumer Trends 2024-2031 12-22-2024 11:51 AM CET | Business, Economy, Finances, Banking & Insurance Press release from: Coherent Market Insights Freezer Bags Market According to the latest research from Coherent Market Insights, the Freezer Bags Market is projected to experience significant growth between 2024 and 2031. This market intelligence report offers in-depth analysis based on thorough research, highlighting current trends, financial performance, and historical data evaluation. The company profiles within the report are derived from the current performance of the Freezer Bags market, considering key factors such as drivers, trends, and challenges, as well as global market share, size, and revenue forecasts for comprehensive insights. To provide a clear understanding, the report examines leading companies, types, applications, and the factors contributing to a positive future outlook. The Freezer Bags market report includes detailed charts, tables, and data analysis, with clear objectives aimed at potential stakeholders. It offers a comprehensive study of the Freezer Bags market, providing valuable insights to support strong growth in the future. This report is designed for a wide range of interested parties, including stakeholders, market participants, investors, researchers, and other individuals associated with the business. ✅ Purchase This Research Report and Get Upto 45% Discount at : https://www.coherentmarketinsights.com/promo/buynow/102234 📈 Overview and Scope of the Report: The Global Freezer Bags Market Analysis Report offers a comprehensive overview of the market size across various segments and countries, including historical data and future forecasts. The report outlines the competitive landscape of the global market, discussing market dynamics, drivers, and segmentation by application, type, region, and manufacturer. It provides both qualitative and quantitative insights into the industry for the regions and countries covered. Additionally, the report highlights key opportunities in the Freezer Bags market, identifying the factors driving growth and expected to continue fueling expansion. It also considers past growth trends, current drivers, and future market developments. The financial standings of key players, including gross profits, sales volumes, revenue, manufacturing costs, and other financial ratios, are accurately assessed. Additionally, analytical tools such as investment evaluation, SWOT analysis, and Porter's Five Forces analysis have been employed to examine the production and distribution capabilities of market participants. Deep-dive Analysis: The Report provides deep-dive qualitative and quantitative analysis on Freezer Bags Market for all the regions and countries covered below: • North America (the United States, Canada, and Mexico) • Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe) • Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia) • South America (Brazil, Argentina, and Rest of South America) • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa) • Each Country is covered in detail, and report provides qualitative and quantitative analysis on Freezer Bags Market on each country. Highlights of Our Report: ⏩Extensive Market Analysis: A deep dive into the manufacturing capabilities, production volumes, and technological innovations within the Freezer Bags Market. ⏩ Corporate Insights: An in-depth review of company profiles, spotlighting major players and their strategic manoeuvres in the market's competitive arena. ⏩Consumption Trends: A detailed analysis of consumption patterns, offering insight into current demand dynamics and consumer preferences. ⏩Segmentation Details: An exhaustive breakdown of end-user segments, depicting the market's spread across various applications and industries. ⏩ Pricing Evaluation: A study of pricing structures and the elements influencing market pricing strategies. ⏩ Future Outlook: Predictive insights into market trends, growth prospects, and potential challenges ahead. ✅ Purchase This Research Report and Get Upto 45% Discount at : https://www.coherentmarketinsights.com/promo/buynow/102234 Reason to Buy this Report: ■ Study of the impact of technological developments on the market and the emerging trends shaping the industry in the coming years. ■ Analysis of the regulatory and policy changes affecting the market and the effects of these changes for market participants. ■ Summary of the competitive landscape in the Freezer Bags market, including profiles of the key players, their market share, and strategies for growth. ■Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. ■Assessment of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. Questions Answered by the Report: (1) Which are the dominant players of the Freezer Bags Market? (2) What will be the size of the Freezer Bags Market in the coming years? (3) Which segment will lead the Freezer Bags Market? (4) How will the market development trends change in the next five years? (5) What is the nature of the competitive landscape of the Freezer Bags Market? (6) What are the go-to strategies adopted in the Freezer Bags Market? Author of this marketing PR: Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. ☎ Contact Us: Mr. Shah Senior Client Partner - Business Development Coherent Market Insights Phone: US: +12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com About Us: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. This release was published on openPR.
European stocks set to start the week higher as global markets rally
CLEVELAND (AP) — The NFL has closed an investigation into sexual assault allegations against Cleveland Browns quarterback Deshaun Watson, who is ending the season on injured reserve for the second year in a row. The league has been reviewing the case for months , trying to determine whether Watson should be punished. “The matter is closed,” league spokesman Brian McCarthy said Friday in an email to The Associated Press. “There was insufficient evidence to support a finding of a violation of the personal conduct policy.” Watson, who served an 11-game suspension in 2022, was accused of assault in Texas by a woman in September. She was seeking more than $1 million in damages before the sides reached a confidential settlement. Watson strongly denied the allegations through his attorney, Rusty Hardin. The 29-year-old Watson suffered a season-ending Achilles tendon rupture in October. He's been rehabbing the injury in hopes of returning next season. The Browns still owe Watson $46 million in each of the next two seasons after they traded three first-round picks to Houston and signed him to a five-year, fully guaranteed $230 million contract that has backfired. Watson has only played in 19 games over three seasons due to the suspension and injuries. He was acquired by the Browns, who were comfortable with his character despite Watson being accused of sexual assault and inappropriate conduct during massage therapy sessions while he played for the Texans. While he's in the clear with the league, Watson's future with Cleveland isn't so certain. His massive contract — and its salary-cap ramifications — has put the Browns in a bind in terms of trying to improve their roster. Cleveland has had a disappointing season after making the playoffs a year ago and could move on from Watson, but the cost would be exorbitant if the team just releases him. The Browns signed Jameis Winston for one season to be Watson's backup. Winston has gone 2-3 as a starter since taking over and he's put some life into Cleveland's offense, which didn't score 20 points or gain 300 yards with Watson before his injury. His 2023 season was ended by a broken bone in his shoulder, requiring surgery. Winston has indicated he would come back, and he could be a viable option as a starter even if the Browns draft a young QB. AP NFL: https://apnews.com/hub/NFLKANSAS CITY 88, PUERTO RICO-RIO PIEDRAS 55Percentages: FG .596, FT .833. 3-Point Goals: 10-23, .435 (Kopp 4-7, Nyeri 3-5, Petty 2-3, Ammons 1-3, Grady 0-2, Hall 0-3). Team Rebounds: 0. Team Turnovers: 1. Blocked Shots: 2 (Nyeri, Petty). Turnovers: 8 (Ammons 2, Hall 2, Ebonkoli, Ijeh, Kopp, Petty). Steals: 6 (Kopp 2, Diallo, Ebonkoli, Grady, Petty). Technical Fouls: None. Percentages: FG .475, FT .462. 3-Point Goals: 5-18, .278 (Ríos 2-7, L.Gonzalez 1-1, Fret 1-2, Hollingsworth 1-2, Fraguada 0-1, Texidor 0-1, Rivera 0-2, Torres 0-2). Team Rebounds: 0. Team Turnovers: 1. Blocked Shots: 1 (Rivera). Turnovers: 12 (L.Gonzalez 4, Fret 3, Benitez 2, A.Gonzalez, Ríos, Torres). Steals: 3 (Benitez, L.Gonzalez, Ramirez). Technical Fouls: None. .
Oyedepo’s jet can’t leave private airstrip without clearance – KeyamoGirls hockey: River Lakes Stars secure home win over Cloquet/Esko/Carlton
Samsung Fires Several Employees For Leaking Images Of Galaxy S25 Ultra Ahead Of India Launch
THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen AMGN today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.